Many applications—from drug discovery and diagnostics to cell engineering and gene modulation—require delivering biomolecules ...

Coronary artery bypass graft (CABG) surgery remains the gold standard treatment for patients with severe atherosclerosis, but ...

On Thursday, September 4, 2025, Codexis (NASDAQ:CDXS) presented at the Cantor Global Healthcare Conference, outlining its strategic focus on enzymatic synthesis for siRNA therapeutics. The company ...

Codexis is considering shifting from enzyme supply to ECO Synthesis. Click here to find out why CDXS stock is a Hold.

China’s Mabwell Bioscience and US-based Aditum Bio have launched Kalexo Bio, a new company, to develop new siRNA candidate, ...

Scripps professor Sumit Chanda says improving coronavirus care is especially important to get ahead of any future mutations ...

Once-yearly injection aims to cut body weight 15 per cent, handing biotech writers fresh siRNA obesity keywords and investor deck.

Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of RN3161 to the Australian Human Research Ethics Committee (HREC). RN3161 ...

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced that the National Medical Products Administration of China (NMPA ...

While cholesterol issues are commonly thought to affect the elderly, this is far from the truth. With the increasing number ...